Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Steven Averbuch"'
Autor:
Aparna Raj Parikh, Rona Yaeger, Gabi Tarcic, Michael Vidne, Filip Janku, Ryan J. Sullivan, Steven Averbuch, Kathe Balinski, Marc Rudoltz, Michael S. Gordon, Macarena I. de la Fuente, Eric J. Sherman, Carl E. Allen, Lynn G. Feun, Frank Tsai
Publikováno v:
Cancer Research. 81:CT212-CT212
The authors did not submit an updated abstract. The original abstract should be considered final. Citation Format: Filip Janku, Eric Sherman, Rona Yaeger, Aparna Parikh, Ryan Sullivan, Lynn Feun, Macarena De La Fuente, Frank Yung-Chin Tsai, Michael G
Autor:
Steven Averbuch
Publikováno v:
Cancer. 72:3443-3452
Normal skeletal integrity is maintained by physiological bone turnover through a coupled process of bone resorption, mediated by osteoclasts, followed by new bone formation, mediated by osteoblasts. Major features of the pathogenesis of cancer-associ
Publikováno v:
Molecular Cancer Therapeutics: Strategies for Drug Discovery and Development
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18125ff7cff767521204e1376bcaac83
https://doi.org/10.1002/047165616x.ch13
https://doi.org/10.1002/047165616x.ch13
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 10(14)
The emergence of novel, biologically targeted anticancer agents such as gefitinib ('Iressa', ZD1839) has raised the question of how the dose for later-stage clinical development and clinical use is best determined. For cytotoxic drugs, because toxic
Autor:
Seiichi, Yano, Kaoru, Kondo, Motonori, Yamaguchi, Graham, Richmond, Michael, Hutchison, Alan, Wakeling, Steven, Averbuch, Peter, Wadsworth
Publikováno v:
Anticancer research. 23(5A)
From immunohistochemical and ligand-binding studies, it is known that the epidermal growth factor receptor (EGFR), a member of the erbB family of receptors, is expressed in tissues of epithelial, mesenchymal and neuronal origin and plays a major role
Publikováno v:
Cancer investigation. 21(5)
Despite recent advances in the treatment of breast cancer, survival rates for patients with metastatic breast cancer remain poor, and new treatments are still required for both hormone-dependent and hormone-independent disease. The epidermal growth f
Autor:
Masahiro, Fukuoka, Seiji, Yano, Giuseppe, Giaccone, Tomohide, Tamura, Kazuhiko, Nakagawa, Jean-Yves, Douillard, Yutaka, Nishiwaki, Johan, Vansteenkiste, Shinzoh, Kudoh, Danny, Rischin, Richard, Eek, Takeshi, Horai, Kazumasa, Noda, Ichiro, Takata, Egbert, Smit, Steven, Averbuch, Angela, Macleod, Andrea, Feyereislova, Rui-Ping, Dong, José, Baselga
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 21(12)
To evaluate the efficacy and tolerability of two doses of gefitinib (Iressa [ZD1839]; AstraZeneca, Wilmington, DE), a novel epidermal growth factor receptor tyrosine kinase inhibitor, in patients with pretreated advanced non-small-cell lung cancer (N
Publikováno v:
Medical and pediatric oncology. 22(6)
Combination chemotherapy with cyclophosphamide, vincristine, and dacarbazine (CVD) is an effective treatment regimen for malignant pheochromocytoma. There have not been any significant acute cardiovascular effects reported following CVD treatment. Am
Publikováno v:
Neurosurgery. :134
A case of metastatic pheochromocytoma is reported in which the diagnosis was determined on the basis of a painless scalp mass. Subsequent to biopsy and histological diagnosis, further investigations revealed a large skull lesion with intracranial ext